跳至主要内容
临床试验/JPRN-UMIN000042240
JPRN-UMIN000042240已完成未知

A clinical study of the efficacy and safety of placenta extract in elderly people with low muscle strength and gait speed -Open label trial- - A research of placenta extract in elderly people with low muscle strength and gait speed

Japan Bio Products Co., Ltd.0 个研究点目标入组 27 人开始时间: 2020年10月28日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
27

研究概览

简要总结

Median gait speed was improved from 0.73 m/s to 0.88 m/s (p<0.001). Median grip strength was unchanged from 14.9 kg before to 15.3 kg after ingestion (p=0.539). Among secondary outcomes evaluated in the exploratory analyses, quality of life was improved.

研究设计

研究类型
Interventional

入排标准

年龄范围
65years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • •1)Persons with allergic symptoms to the test food and excipients 2) Persons with difficulty walking or with diseases that are known to affect their ability to move (known muscular disease, peripheral vascular disease causing intermittent claudication, central and peripheral nerve disease (e.g. Parkinson's disease, spinal cord disease, motor neuron disease, etc.), severe dementia, severe diabetes). 3) Any person with a history or suspicion of being affected by cachexia 4) Anyone taking a BCAA supplement. 5) Those who continue to take placenta extract 6) Those who have participated in another clinical trial within the past six months 7) A person who is judged by the principal investigator to be unsuitable to participate in the clinical trial.

研究者

相似试验